Showing results (1821-1830 of 2,452) with videos related to

Sort By:
Pageof 246
Clinical and Translational Science|November 20, 2021
Pharmacokinetics of bempedoic acid in patients with renal impairmentBenny M Amore, William J Sasiela, Daniel K Ries, et al.
Clinical and Translational Science|November 10, 2021
Lay understandings of drug-gene interactions: The right medication, the right dose, at the right time, but what are the right words?Karen M Meagher, Kelsey Stuttgen Finn, Susan H Curtis, et al.
Clinical and Translational Science|November 10, 2021
Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysisEdwin Lam, Yi Ting Kayla Lien, Walter K Kraft, et al.
Clinical and Translational Science|December 3, 2021
A phase I, first-in-human, randomized dose-escalation study of anti-activated factor XII monoclonal antibody garadacimabAndrew McKenzie, Anthony Roberts, Sourabh Malandkar, et al.
Clinical and Translational Science|December 6, 2021
Natural killer cells in liver transplantation: Can we harness the power of the immune checkpoint to promote tolerance?Jennifer Halma, Stephen Pierce, Rebecca McLennan, et al.
Clinical and Translational Science|November 11, 2018
Comparison of Electrocardiographic Biomarkers for Differentiating Drug-Induced Single vs. Multiple Cardiac Ion Channel BlockMarina Brockway, Jay W Mason, Brian P Brockway
Clinical and Translational Science|March 29, 2019
Exposure-Response Modeling and Simulation of Progression-Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid CancerJoachim Grevel, Garrit Jentsch, Rupert Austin, et al.
Clinical and Translational Science|September 28, 2019
Effect of Genetic and Nongenetic Factors on the Clinical Response to Mineralocorticoid Receptor Antagonist Therapy in Egyptians with Heart FailureNeven M Sarhan, Mohamed H Shahin, Nihal M El Rouby, et al.
Clinical and Translational Science|January 25, 2021
Population pharmacokinetic and exposure-response analyses of ivosidenib in patients with IDH1-mutant advanced hematologic malignanciesXuemin Jiang, Russ Wada, Bill Poland, et al.
Pageof 246